Go Pro

Envista (NVST) Competitors

Envista logo
$27.21 +0.28 (+1.04%)
As of 08/21/2026 03:58 PM Eastern

NVST vs. ALGN, XRAY, BRBR, COO, and SOLV

Should you buy Envista stock or one of its competitors? Envista's main competitors and comparable companies include Align Technology (ALGN), DENTSPLY SIRONA (XRAY), BellRing Brands (BRBR), Cooper Companies (COO), and Solventum (SOLV). Companies are selected based on similarities in market, industry, and size.

How does Envista compare to Align Technology?

Align Technology (NASDAQ:ALGN) and Envista (NYSE:NVST) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

Align Technology has a beta of 1.65, suggesting that its stock price is 65% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

In the previous week, Align Technology had 5 more articles in the media than Envista. MarketBeat recorded 12 mentions for Align Technology and 7 mentions for Envista. Align Technology's average media sentiment score of 1.18 beat Envista's score of 1.16 indicating that Align Technology is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Align Technology
9 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Envista
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Align Technology has higher revenue and earnings than Envista. Align Technology is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Align Technology$4.03B2.89$410.35M$5.7528.27
Envista$2.72B1.61$47M$0.5846.91

Align Technology presently has a consensus price target of $206.36, indicating a potential upside of 26.95%. Envista has a consensus price target of $29.31, indicating a potential upside of 7.71%. Given Align Technology's stronger consensus rating and higher probable upside, analysts plainly believe Align Technology is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67
Envista
0 Sell rating(s)
9 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.50

Align Technology has a net margin of 9.99% compared to Envista's net margin of 3.33%. Align Technology's return on equity of 15.86% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
Align Technology9.99% 15.86% 10.32%
Envista 3.33%7.88%4.33%

88.4% of Align Technology shares are owned by institutional investors. 0.8% of Align Technology shares are owned by company insiders. Comparatively, 1.0% of Envista shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Align Technology beats Envista on 14 of the 16 factors compared between the two stocks.

How does Envista compare to DENTSPLY SIRONA?

DENTSPLY SIRONA (NASDAQ:XRAY) and Envista (NYSE:NVST) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership.

Envista has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DENTSPLY SIRONA$3.68B0.59-$598M-$2.75N/A
Envista$2.72B1.61$47M$0.5846.91

DENTSPLY SIRONA has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market. Comparatively, Envista has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

95.7% of DENTSPLY SIRONA shares are held by institutional investors. 0.5% of DENTSPLY SIRONA shares are held by company insiders. Comparatively, 1.0% of Envista shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Envista has a net margin of 3.33% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
DENTSPLY SIRONA-14.99% 20.84% 5.32%
Envista 3.33%7.88%4.33%

In the previous week, Envista had 2 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 7 mentions for Envista and 5 mentions for DENTSPLY SIRONA. Envista's average media sentiment score of 1.16 beat DENTSPLY SIRONA's score of 1.10 indicating that Envista is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DENTSPLY SIRONA
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Envista
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

DENTSPLY SIRONA presently has a consensus price target of $13.38, suggesting a potential upside of 22.57%. Envista has a consensus price target of $29.31, suggesting a potential upside of 7.71%. Given DENTSPLY SIRONA's higher probable upside, equities analysts clearly believe DENTSPLY SIRONA is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DENTSPLY SIRONA
3 Sell rating(s)
9 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.00
Envista
0 Sell rating(s)
9 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.50

Summary

Envista beats DENTSPLY SIRONA on 12 of the 17 factors compared between the two stocks.

How does Envista compare to BellRing Brands?

Envista (NYSE:NVST) and BellRing Brands (NYSE:BRBR) are related companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations, media sentiment and institutional ownership.

95.0% of BellRing Brands shares are held by institutional investors. 1.0% of Envista shares are held by insiders. Comparatively, 1.5% of BellRing Brands shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Envista has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market. Comparatively, BellRing Brands has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market.

BellRing Brands has a net margin of 7.28% compared to Envista's net margin of 3.33%. Envista's return on equity of 7.88% beat BellRing Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Envista3.33% 7.88% 4.33%
BellRing Brands 7.28%-33.04%15.63%

In the previous week, BellRing Brands had 3 more articles in the media than Envista. MarketBeat recorded 10 mentions for BellRing Brands and 7 mentions for Envista. Envista's average media sentiment score of 1.16 beat BellRing Brands' score of 0.33 indicating that Envista is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BellRing Brands
3 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

BellRing Brands has lower revenue, but higher earnings than Envista. BellRing Brands is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.72B1.61$47M$0.5846.91
BellRing Brands$2.32B0.51$216.20M$1.427.20

Envista currently has a consensus target price of $29.31, suggesting a potential upside of 7.71%. BellRing Brands has a consensus target price of $19.82, suggesting a potential upside of 93.76%. Given BellRing Brands' higher possible upside, analysts plainly believe BellRing Brands is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
0 Sell rating(s)
9 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.50
BellRing Brands
1 Sell rating(s)
8 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.44

Summary

BellRing Brands beats Envista on 9 of the 17 factors compared between the two stocks.

How does Envista compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and Envista (NYSE:NVST) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends, risk and media sentiment.

Cooper Companies presently has a consensus price target of $81.64, suggesting a potential upside of 7.11%. Envista has a consensus price target of $29.31, suggesting a potential upside of 7.71%. Given Envista's stronger consensus rating and higher probable upside, analysts plainly believe Envista is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.35
Envista
0 Sell rating(s)
9 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.50

Cooper Companies has higher revenue and earnings than Envista. Envista is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B3.63$374.90M$1.1864.59
Envista$2.72B1.61$47M$0.5846.91

24.4% of Cooper Companies shares are held by institutional investors. 2.1% of Cooper Companies shares are held by insiders. Comparatively, 1.0% of Envista shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Cooper Companies has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market. Comparatively, Envista has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

Cooper Companies has a net margin of 5.57% compared to Envista's net margin of 3.33%. Cooper Companies' return on equity of 10.88% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies5.57% 10.88% 7.27%
Envista 3.33%7.88%4.33%

In the previous week, Cooper Companies had 28 more articles in the media than Envista. MarketBeat recorded 35 mentions for Cooper Companies and 7 mentions for Envista. Envista's average media sentiment score of 1.16 beat Cooper Companies' score of 0.97 indicating that Envista is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
20 Very Positive mention(s)
6 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
2 Very Negative mention(s)
Positive
Envista
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Cooper Companies beats Envista on 12 of the 16 factors compared between the two stocks.

How does Envista compare to Solventum?

Envista (NYSE:NVST) and Solventum (NYSE:SOLV) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

Solventum has higher revenue and earnings than Envista. Solventum is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.72B1.61$47M$0.5846.91
Solventum$8.33B1.83$1.56B$8.1810.96

Solventum has a net margin of 17.26% compared to Envista's net margin of 3.33%. Solventum's return on equity of 25.09% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista3.33% 7.88% 4.33%
Solventum 17.26%25.09%8.78%

In the previous week, Envista had 3 more articles in the media than Solventum. MarketBeat recorded 7 mentions for Envista and 4 mentions for Solventum. Envista's average media sentiment score of 1.16 beat Solventum's score of 0.91 indicating that Envista is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Solventum
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Envista currently has a consensus target price of $29.31, indicating a potential upside of 7.71%. Solventum has a consensus target price of $91.64, indicating a potential upside of 2.23%. Given Envista's higher probable upside, research analysts clearly believe Envista is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
0 Sell rating(s)
9 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.50
Solventum
1 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.54

Envista has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market. Comparatively, Solventum has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market.

Summary

Solventum beats Envista on 9 of the 15 factors compared between the two stocks.

Get Envista News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVST and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVST vs. The Competition

MetricEnvistaHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$4.37B$6.02B$7.37B$24.30B
Dividend YieldN/A1.75%2.53%3.70%
P/E Ratio46.9126.67272.6030.31
Price / Sales1.6145.38618.9619.89
Price / Cash12.5333.2478.6232.49
Price / Book1.426.2313.056.77
Net Income$47M$150.07M$3.47B$1.07B
7 Day Performance-2.98%0.69%2.09%-0.65%
1 Month Performance4.10%8.91%6.64%3.38%
1 Year Performance25.57%8.07%25.02%14.90%

Envista Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVST
Envista
2.1507 of 5 stars
$27.21
+1.0%
$29.31
+7.7%
+25.6%$4.37B$2.72B46.9112,000
ALGN
Align Technology
4.5196 of 5 stars
$176.04
+1.4%
$206.36
+17.2%
+8.7%$12.44B$4.03B30.6220,290
XRAY
DENTSPLY SIRONA
4.5636 of 5 stars
$11.66
-3.8%
$13.38
+14.8%
-25.5%$2.42B$3.68BN/A14,000
BRBR
BellRing Brands
4.4221 of 5 stars
$11.42
-1.2%
$19.82
+73.6%
-74.4%$1.34B$2.32B8.04380
COO
Cooper Companies
2.8047 of 5 stars
$76.32
+2.8%
$81.36
+6.6%
+1.3%$14.48B$4.09B64.6815,000

Related Companies and Tools


This page (NYSE:NVST) was last updated on 8/23/2026 by MarketBeat.com Staff.
From Our Partners